4/A//SEC Filing
Gitman Paul 4/A
Accession 0001062993-18-003579
CIK 0000875622other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 5:51 PM ET
Size
7.1 KB
Accession
0001062993-18-003579
Insider Transaction Report
Form 4/AAmended
Gitman Paul
Director
Transactions
- Sale
Common Stock, $0.001 par value
2018-08-23$51.27/sh−5,425$278,166→ 46,400 total - Sale
Common Stock, $0.001 par value
2018-08-24$51.09/sh−6,400$326,962→ 40,000 total
Footnotes (2)
- [F1]The selling price of $51.2748 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $50.25 to $52.445. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This amendment is being provided to report the price range of the transactions in connection with the weighted average sale price reported on this line.
- [F2]The selling price of $51.0878 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $50.24 to $51.52. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This amendment is being provided to report the price range of the transactions in connection with the weighted average sale price reported on this line.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001375378
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 5:51 PM ET
- Size
- 7.1 KB